Armistice Capital »

Impinj shares owned by Armistice Capital

Quarter-by-quarter ownership of Impinj (PI) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Impinj

Tip: Access up to 7 years of quarterly data

All positions including Impinj held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Impinj by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $465k 3.2k 143.23

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Impinj

FMR
BlackRock
Vanguard Portfolio Management
State Street Corporation
Capital Research and Management Company - Division 3
Vanguard Capital Management
Capital World Investors
Millennium Management
American Century Companies
Sylebra Capital
Chevy Chase Trust Holdings
Geode Capital Management
Manufacturers Life Insurance Company
UBS Group
Ameriprise Financial

View all funds holding Impinj